,
The EU's clinical trial landscape is changing with the full adoption of Regulation No 536/2014, shifting toward harmonization, digitalization, and transparency to improve safety and efficiency. This whitepaper examines emerging trends, practical impacts, and the vital role of regulatory partners like Freyr, offering insights for professionals and the public.
Fill the form below to download the White Paper
